Status:

COMPLETED

Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis

Lead Sponsor:

The Nazareth Hospital, Israel

Conditions:

Adrenal Suppression

Eligibility:

All Genders

18+ years

Brief Summary

To evaluate the effect of intra-articular corticosteroid injection (IACI) of depot preparation of betamethasone on the hypothalamic-pituitary-adrenal (HPA) axis, in patients with osteoarthritis of the...

Detailed Description

Consecutive patients attending the rheumatology or orthopedic clinic with osteoarthritic knee pain, not responding satisfactorily to medical or physical therapy were allocated to group-1 after consent...

Eligibility Criteria

Inclusion

  • Osteoarthritis of the knee

Exclusion

  • Had steroids in the last 3 months. Allergic to steroids

Key Trial Info

Start Date :

October 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2013

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT01799408

Start Date

October 1 2012

End Date

February 1 2013

Last Update

February 26 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis | DecenTrialz